| Autor: |
Phatak S; 1 Department of Mechanical Engineering, University of Minnesota , Minneapolis, Minnesota., Natesan H; 1 Department of Mechanical Engineering, University of Minnesota , Minneapolis, Minnesota., Choi J; 2 Department of Engineering, East Carolina University , Greenville, North Carolina., Brockbank KGM; 3 Department of Bioengineering, Clemson University , South Carolina.; 4 Tissue Testing Technologies , Charleston, South Carolina., Bischof JC; 1 Department of Mechanical Engineering, University of Minnesota , Minneapolis, Minnesota.; 5 Biomedical Engineering, University of Minnesota , Minneapolis, Minnesota. |
| Jazyk: |
angličtina |
| Zdroj: |
Biopreservation and biobanking [Biopreserv Biobank] 2018 Aug; Vol. 16 (4), pp. 270-277. Date of Electronic Publication: 2018 Jun 29. |
| DOI: |
10.1089/bio.2018.0006 |
| Abstrakt: |
Cryopreservation represents one if not the only long-term option for tissue and perhaps future organ banking. In one particular approach, cryopreservation is achieved by completely avoiding ice formation (or crystallization) through a process called vitrification. This "ice-free" approach to tissue banking requires a combination of high-concentration cryoprotective additives such as M22 (9.4 M), VS55 (8.4 M), or DP6 (6 M) and sufficiently fast rates of cooling and warming to avoid crystallization. In this article, we report the temperature-dependent specific heat capacity of the above-mentioned cryoprotective additives in small volumes (10 mg sample pans) at rates of 5°C/min and 10°C/min using a commercially available differential scanning calorimetry (TA Instruments Q1000), in the temperature range of -150°C to 30°C. This data can be utilized in heat-transfer models to predict thermal histories in a cryopreservation protocol. More specifically, the effects of temperature dependence of specific heat due to the presence of three different phases (liquid, ice, and vitreous phase) can dramatically impact the thermal history and therefore the outcome of the cryopreservation procedure. The crystallization potential of these cryoprotectants was also investigated by studying cases of maximal and minimal crystallization in VS55 and DP6, where M22 did not crystallize under any rates tested. To further reduce crystallization in VS55 and DP6, a stabilizing sugar (sucrose) was added in varying concentrations (0.15 M and 0.6 M) and was shown to further reduce crystallization, particularly in VS55, at modest rates of cooling (1°C/min, 5°C/min, and 10°C/min). |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
